Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2680-2016Class II

NIO-A / NIO-P is an instant IO access device comprises housing with spring load mechanism that injects a...

Waismed Ltd. / initiated 2016-08-18 / Terminated / root cause: design

Waismed Ltd began a recall of NIO-A / NIO-P is an instant IO access device comprises housing with spring load mechanism that injects a trocar needle into the bone marrow of a patient and... on . FDA classified it as Class II and gives the reason as "WaisMed received a report in which during the operation of the NIO-A, the needle was not released from the device as expected. The device was placed on the floor and after several minutes the needle was released...". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-2680-2016
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Waismed Ltd.
Product
NIO-A / NIO-P is an instant IO access device comprises housing with spring load mechanism that injects a trocar needle into the bone marrow of a patient and allows connection of syringe or IV administration set. The NIO-A is intended for adults above 12 years old and the NIO-P is intended for pediatric patients 3 - 12 years of age.
Product code
FMI Needle, Hypodermic, Single Lumen
Reason for recall
WaisMed received a report in which during the operation of the NIO-A, the needle was not released from the device as expected. The device was placed on the floor and after several minutes the needle was released spontaneously. NIO-A and the NIO-P models have the same activation mechanism. However, none of the affected lots of the NIO-A are distributed in the US, and thus the company is only recalling a single lot of NIO-P in the US.
Root cause tag
design
FDA root cause
Component design/selection
Action
The firm emailed the US Consignees on August 18, 2016 that they were conducting a recall on the NIO/A and NIO/P products. The US distributor shall contact the customers and will collect the products from each of the customers. The recalled products shall be moved to Storage quarantine within one week. The company shall keep track on the process and the recall efficacy.
Quantity in commerce
50
Distribution
WI, TX, CA, LA and the following countries: UK, Spain, Poland, Israel, Czech Republic, France, Belgium, Denmark, Italy, Cyprus, Austria, Greece, Slovenia, Australia, Germany, Estonia, New Zealand, Switzerland, Costa Rica, Guatemala, Canada, Malaysia, Poland, Singapore, Lithuania, Romania
Product codes and lots
1620005

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2680-2016
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2680-2016Class IITerminatedVoluntary: Firm initiated